The ABCs of Antibody-Drug Conjugates (ADCs): The Basics About ADCs for the Treatment of mBC

Antibody-drug conjugates (ADCs) are a newer class of therapies that have shown great potential in treatment of mBC. Watch as Dr. Joyce O’Shaughnessy walks through a detailed 3D animation and outlines the indications and mechanisms of action of ADCs in the treatment of mBC in this Monday Morning Joe episode.

Bookmark this page and check back for new episodes!
   • Monday Morning Joe in mBC  

Episode 1: The ABCs of Antibody-Drug Conjugates (ADCs): The Basics About ADCs for the Treatment of Metastatic Breast Cancer (mBC)

Episode 2: Lay the Groundwork: Analyzing the Data Supporting Antibody-Drug Conjugates (ADCs) in Metastatic Breast Cancer (mBC)

Episode 3: Look Before You Leap: Prevention and Mitigation of Treatment-Emergent Adverse Events (TEAEs)

Episode 4: Hot Off the Presses: The Most Recent Data on Antibody-Drug Conjugates (ADCs) for the Treatment of Metastatic Breast Cancer (mBC)

ExchangeCME.com is an online community of more than 60,000 active healthcare professionals who have access to a variety of enduring educational activities and other disease state–focused resources. The Website’s core mission is to support patient-centered care via education that is tailored to the needs of various clinician audiences.

By consolidating evidence-based resources and hosting only accredited educational programs without any promotional content or advertising, ExchangeCME.com serves as an independent, trusted, and balanced source of free CME/CE for physicians, nurses, pharmacists, and other healthcare providers.

Follow us on socials!
  / exchangecme  
  / exchangecme  
  / 10863550  

#breastcancer
#breastcancerawareness
#breastcancertreatment
#breastcancerawarenessmonth
#breastcancerpatient

Standard License and Enhance License Music Track ID 498181 – Monetization ID 9U2PR4M3SXKWCJMT